Massive Bio Company
Massive Bio is an AI powered oncology platform that connects patients to clinical trials while enabling pharma to get access to patients.
Investors
.png)
Funding Status:
Early Stage Venture
Industry:
Medical BioTech
Estimated Revenue:
$1M to $10M
Technology:
['BioTech & HealthTech']
Headquarters:
New York, New York, United States
Total Funding:
137650394
Last Funding Date:
2022-06-02
Last Funding Type:
Venture - Series Unknown
Investor Type:
support@massivebio.com
Employee Number:
11-50
Investors Number:
13.0
Founded Date:
2015-05-04